Alwine B Kruisselbrink

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 4

Top Topics

Dna Damage Response

Mesenchymal Stem Cells

Histone Deacetylase

Top Venues

Laboratory investigation; a journal of technical methods and pathology

This page only lists publications with an associated author ORCID identifier.

Publications

Natasja Franceschini, Raffaele Gaeta, Paul Krimpenfort, Inge H Briaire-de Bruijn, Alwine B Kruisselbrink, Károly Szuhai, Ieva Palubeckaitė, Anne-Marie Cleton-Jansen, Judith V M G Bovée
A murine mesenchymal stem cell model for initiating events in osteosarcomagenesis points to CDK4/CDK6 inhibition as a therapeutic target. Laboratory investigation; a journal of technical methods and pathology 102 (4) (2021)
Natasja Franceschini, Bas Verbruggen, Marianna A Tryfonidou, Alwine B Kruisselbrink, Hans Jacobus Baelde, Karin E de Visser, Károly Szuhai, Anne-Marie Cleton-Jansen, Judith V M G Bovée
Transformed Canine and Murine Mesenchymal Stem Cells as a Model for Sarcoma with Complex Genomics. Cancers 13 (5) (2021)
Sanne Venneker, Alwine B Kruisselbrink, Zuzanna Baranski, Ieva Palubeckaite, Inge H Briaire-de Bruijn, Jan Oosting, Pim J French, Erik H J Danen, Judith V M G Bovée
Beyond the Influence of IDH Mutations: Exploring Epigenetic Vulnerabilities in Chondrosarcoma. Cancers 12 (12) (2020)
Sanne Venneker, Alwine B Kruisselbrink, Inge H Briaire-de Bruijn, Yvonne de Jong, Andre J van Wijnen, Erik H J Danen, Judith V M G Bovée
Inhibition of PARP Sensitizes Chondrosarcoma Cell Lines to Chemo- and Radiotherapy Irrespective of the IDH1 or IDH2 Mutation Status. Cancers 11 (12) (2019)